BIOSYNTHESIS OF ANANDAMIDE--A NOVEL EICOSANOID

新型二十烷酸阿南达胺的生物合成

基本信息

项目摘要

The main goal of this application is to characterize the process involved in agonist-stimulated synthesis of anandamide (arachidonylethanolamine) in intact cells. A preliminary report (8) from this laboratory showed that agents capable of activating phospholipases to release free arachidonic acid appear to also promote anandamide synthesis. This observation has provided the basis for the hypothesis that we wish to test in this proposal, namely, that physiological control of anandamide synthesis resides in the regulation of cellular phospholipase activity. This is the situation for the other members of the eicosanoid family of which anandamide is a novel member. Anandamide has been suggested to be a putative endogenous cannabimimetic substance, however, its significance will probably extend beyond the area of drug abuse. Indeed, it has been speculated that it may represent a class of novel neuroregulatory agents because of its distribution and biological effects. Receptors that bind anandamide have also been observed in peripheral cells associated with the immune system suggesting that it may have functions outside of the central nervous system as well. Thus, an understanding of how its tissue levels are controlled becomes a matter of some importance. Specific questions to be addressed in this proposal are; (a) What are the agonists that are able to stimulate anandamide synthesis? (b) Are cells in culture suitable experimental models for such studies; (c) Are receptors required for synthesis in intact cells? (d) Which enzymic mediators are responsible for anandamide synthesis? (e) What are the important precursors for cellular anandamide synthesis? Based on what is known about anandamide's properties, its significance may be that it is involved in novel neuroregulatory processes that control CNS functions such as mood, motor coordination, cognitive ability, time-sense and self-perception. In addition, peripheral effects on the cardiovascular, immune, endocrine and respiratory systems may also be part of anandamides' spectrum of activities. The proposed studies may provide useful models for the development of therapeutic approaches to diseases such as multiple sclerosis, Huntington's, etc. where the use of cannabinoids has been explored. Methods for controlling endogenous anandamide synthesis in vivo could prove to be beneficial in relieving the symptoms of these types of ailments. Finally, it is possible that anandamide is only one member of a family of regulatory agents and that data resulting from this project will provide evidence for the existence of other more potent or specific "anandamides".
这个应用程序的主要目标是描述所涉及的过程

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SUMNER HOWARD BURSTEIN其他文献

SUMNER HOWARD BURSTEIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SUMNER HOWARD BURSTEIN', 18)}}的其他基金

The elmiric acids: biologically active anandamide analogs.
elmiric Acids:具有生物活性的 anandamide 类似物。
  • 批准号:
    7727687
  • 财政年份:
    2009
  • 资助金额:
    $ 16.13万
  • 项目类别:
The elmiric acids: biologically active anandamide analogs.
elmiric Acids:具有生物活性的 anandamide 类似物。
  • 批准号:
    7894890
  • 财政年份:
    2009
  • 资助金额:
    $ 16.13万
  • 项目类别:
Endocannabinoid Analogs as Anti-inflammatory Agents
作为抗炎剂的内源性大麻素类似物
  • 批准号:
    7106374
  • 财政年份:
    2004
  • 资助金额:
    $ 16.13万
  • 项目类别:
Endocannabinoid Analogs as Anti-inflammatory Agents
作为抗炎剂的内源性大麻素类似物
  • 批准号:
    6951593
  • 财政年份:
    2004
  • 资助金额:
    $ 16.13万
  • 项目类别:
Endocannabinoid Analogs as Anti-inflammatory Agents
作为抗炎剂的内源性大麻素类似物
  • 批准号:
    6749403
  • 财政年份:
    2004
  • 资助金额:
    $ 16.13万
  • 项目类别:
Endocannabinoid Analogs as Anti-inflammatory Agents
作为抗炎剂的内源性大麻素类似物
  • 批准号:
    7678732
  • 财政年份:
    2004
  • 资助金额:
    $ 16.13万
  • 项目类别:
NON PSYCHOACTIVE CANNABINOIDS WITH THERAPEUTIC POTENTIAL
具有治疗潜力的非精神活性大麻素
  • 批准号:
    6175550
  • 财政年份:
    1999
  • 资助金额:
    $ 16.13万
  • 项目类别:
NON PSYCHOACTIVE CANNABINOIDS WITH THERAPEUTIC POTENTIAL
具有治疗潜力的非精神活性大麻素
  • 批准号:
    2902241
  • 财政年份:
    1999
  • 资助金额:
    $ 16.13万
  • 项目类别:
NON PSYCHOACTIVE CANNABINOIDS WITH THERAPEUTIC POTENTIAL
具有治疗潜力的非精神活性大麻素
  • 批准号:
    6378830
  • 财政年份:
    1999
  • 资助金额:
    $ 16.13万
  • 项目类别:
NON PSYCHOACTIVE CANNABINOIDS WITH THERAPEUTIC POTENTIAL
具有治疗潜力的非精神活性大麻素
  • 批准号:
    6515659
  • 财政年份:
    1999
  • 资助金额:
    $ 16.13万
  • 项目类别:

相似海外基金

Periplasmic amidases in bacterial cell division.
细菌细胞分裂中的周质酰胺酶。
  • 批准号:
    2097254
  • 财政年份:
    2018
  • 资助金额:
    $ 16.13万
  • 项目类别:
    Studentship
Investigating trivalent chelates as inhibitors of bacterial amidases
研究三价螯合物作为细菌酰胺酶抑制剂
  • 批准号:
    497252-2016
  • 财政年份:
    2016
  • 资助金额:
    $ 16.13万
  • 项目类别:
    University Undergraduate Student Research Awards
Development of adjunctive therapies directed at S. aureus amidases
针对金黄色葡萄球菌酰胺酶的辅助疗法的开发
  • 批准号:
    8912086
  • 财政年份:
    2014
  • 资助金额:
    $ 16.13万
  • 项目类别:
Development of adjunctive therapies directed at S. aureus amidases
针对金黄色葡萄球菌酰胺酶的辅助疗法的开发
  • 批准号:
    8702797
  • 财政年份:
    2014
  • 资助金额:
    $ 16.13万
  • 项目类别:
Development of adjunctive therapies directed at S. aureus amidases
针对金黄色葡萄球菌酰胺酶的辅助疗法的开发
  • 批准号:
    8800543
  • 财政年份:
    2014
  • 资助金额:
    $ 16.13万
  • 项目类别:
NOVEL AMIDASES FOR SYNTHETIC ORGANIC CHEMISTRY
用于合成有机化学的新型酰胺酶
  • 批准号:
    6211089
  • 财政年份:
    2000
  • 资助金额:
    $ 16.13万
  • 项目类别:
DEVELOPMENT OF AMIDASES FOR B-LACTAM MODIFICATION
用于 B-内酰胺修饰的酰胺酶的开发
  • 批准号:
    3498043
  • 财政年份:
    1988
  • 资助金额:
    $ 16.13万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了